Dr. Patrick DiPaolo, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Patrick DiPaolo, who serves patients in Montclair, New Jersey.

A highly trained hematologist-oncologist, Dr. DiPaolo sees patients at his private practice in Montclair, New Jersey. He can also be found on staff at Clara Maass Medical Center, Mountainside Medical Center, and St. Mary’s General Hospital.

A native of Italy, he earned his medical degree from the Sapienza University of Rome in 1983. After relocating to the United States, he completed his fellowship in hematology at the University Hospital in 1989.

With an unwavering commitment to his specialty, the doctor is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

As a testament of his dedication to his field, Dr. DiPaolo has been the recipient of the Montclair Super Doctors Award (2014-2021), Patients' Choice Award (2014, 2012, 2011, 2010, 2009, 2008), Compassionate Doctor Recognition (2014, 2013, 2012, 2011, 2010), Patients' Choice 5th Anniversary Award (2012), Compassionate Doctor Award - 5 Year Honoree (2014), and Top 10 Doctor - State (2014).

On a more personal note, he is fluent in both English and Italian.

Recommended Articles

• Microsoft Co-Founder Paul Allen Beats Lymphoma Twice

  Beating any type of cancer is a major feat in itself, but billionaire and Microsoft co-founder Paul Allen has defeated lymphoma not once, but twice.Paul's storyNeedless to say, being the co-founder of Microsoft is a pretty big deal. As an American digital pioneer, Paul has been on top of the world....

• How is Multiple Myeloma Diagnosed?

  Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

• The Link Between Lymphoma Radiotherapy and Mesothelioma

  One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...

• The Effect of Sunshine on Lymphoma

  Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research

  There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...